Documentary record · GOVERNMENT AMENDMENTS TABLED

UK Government tables three Health Bill amendments affecting the MHRA statutory framework

PARLIAMENTARY SCRUTINY PENDING

Event date

September 1, 2026

Jurisdiction

United Kingdom

Issuing body

UK Government / MHRA

Action type

GOVERNMENT AMENDMENTS TABLED

Lifecycle state

PARLIAMENTARY SCRUTINY PENDING

Verification date

1 September 2026

None yet. Tabled government amendments are proposals before Parliament: no regulation is in force, and no medical-device licensing regime is established.

What this establishes

  • Three government amendments were tabled on 1 September.
  • They concern medicines and device information-sharing powers, making medicines and device legislation easier to update, and authority supporting development of a future medical-device licensing regime.

What this does not establish

  • That the UK has adopted a device licensing regime.
  • That MHRA has new powers today.
  • That the amendments will survive scrutiny in their tabled form.

Why it matters

The structural question is delegation. A regulator able to update technical requirements without returning to primary legislation can keep pace with software and AI devices; the same power reduces parliamentary control over rules that carry real consequences for patients and manufacturers. Both sides of that trade are stated on the tracker.

The open question

Should a medical-device regulator hold a standing statutory power to update technical regulation without fresh primary legislation? The counterargument is not procedural fussiness: rules made without parliamentary passage are harder to contest and easier to reverse without notice.

Primary source

Register: data/events.json · record id uk-mhra-health-bill-amendments-2026-09-01.